Biocon's subsidiary, Biocon Biologics, has introduced Nepexto, a biosimilar to Enbrel (Etanercept), in Australia for treating autoimmune di...

Zydus Lifesciences gets USFDA nod for Celecoxib capsules. The approval includes various strengths of the drug. It will manufacture the drug...

Lupin Ltd has partnered with Zentiva Group to commercialize its biosimilar 'Certolizumab Pegol' across global markets. The agreement grants...

A recent study published in the journal Rheumatology reveals that rheumatic diseases, such as autoimmune disorders affecting joints, muscle...

From diabetes to infertility and cardiovascular problems, childhood obesity can lead to many health scares.

In total, there are more than 100 different types of arthritis.

The company has received abbreviated new drug application (ANDA) approval for its Celecoxib capsules in the strengths of 50 mg, 100 mg, 200...

Mumbai based Lupin pharma and Japan's Nichi-Iko have tied up for the distribution, promotion and sale of Lupin’s recently-filed biosimilar ...

Children with physical and mental health problems experience significant decline in their quality of life.

Levetiracetam injection is used for treatment of partial onset seizures, myoclonic seizures in patients with juvenile myoclonic epilepsy, a...

Zydus Cadila today launched biosimilar of Adalimumab, used for treatment of auto immune disorders, at a price much lower than the innovator...

The company has also received tentative approvals for its product in strengths of 100 mg, 200 mg and 400 mg from the FDA.

Cadila Healthcare today said it has received US health regulator's nod to market Etodolac extended release tablets, used in the treatment o...

Drug major Cipla said it has launched biosimilar of Etanercept under the brand name 'Etacept' used for treatment of rheumatic disorders in ...

Noone had heard of cholesterol when Leonardo da Vinci made Mona Lisa portrait.